Corticotropin releasing hormone and the skin

Frontiers in Bioscience

Volumn 11, Issue SUPPL. 1, 2006, Pages 2230-2248

  Slominski, Andrzej ^a,e   Zbytek, Blazej ^a,b   Zmijewski, Michal ^a   Slominski, Radomir M ^a   Kauser, Sobia ^c   Wortsman, Jacobo ^d   Tobin, Desmond J ^c  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

^c UNIVERSITY OF BRADFORD   (United Kingdom)

^d SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Department of Pathology and Laboratory Medicine ^*  (United States)

Author keywords

Corticotropin; CRH; CRH R1; CRH R2; Hormone; Human Skin; Review; Urocortin

Indexed keywords

EID: 33744821910     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1966     Document Type: Review

References (114)

1. Grammatopoulos, D. K. & G. P. Chrousos: Functional characteristics of CRH receptors and potential clinical applications of CRH-receptor antagonists. Trends Endocrinol Metab, 13, 436-44 (2002)
2. Hillhouse, E. W., H. Randeva, G. Ladds & D. Grammatopoulos: Corticotropin-releasing hormone receptors. Biochem Soc Trans, 30, 428-32 (2002)
3. Chrousos, G. P.: The Hypothalamic-Pituitary-Adrenal Axis and Immune-Mediated Inflammation. N Engl J Med, 332, 1351-1363 (1995)
4. Slominski, A.: Neuroendocrine system of the skin. Dermatology, 211, 199-208 (2005)
5. Slominski, A., Wortsman, J., Linton, E., Pisarchik, A., Zbytek, B.: The skin as a model for the immunomodulatory effects of corticotropin-releasing hormone. In: Mind over Matter - Regulation of Peripheral Inflammation by the CNS. Ed: M. Schaefer, Stein, C. Birkhaeuser Verlag, Basel, Boston, Berlin (2003)
6. Slominski, A., J. Wortsman, A. Pisarchik, B. Zbytek, E. A. Linton, J. E. Mazurkiewicz & E. T. Wei: Cutaneous expression of corticotropin-releasing hormone (CRH), urocortin, and CRH receptors. Faseb J, 15, 1678-93 (2001)
7. Slominski, A., J. Wortsman, T. Luger, R. Paus & S. Solomon: Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev, 80, 979-1020 (2000)
8. Perrin, M. H. & W. W. Vale: Corticotropin releasing factor receptors and their ligand family. Ann NY Acad Sci, 885, 312-328 (1999)
9. Spiess, J., J. Rivier, C. Rivier & W. Vale: Primary structure of corticotropin-releasing factor from ovine hypothalamus. Proc Natl Acad Sci U S A, 78, 6517-21 (1981)
10. Vale, W., J. Spiess, C. Rivier & J. Rivier: Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science, 213, 1394-7 (1981)
11. Aguilera, G., C. Rabadan-Diehl & M. Nikodemova: Regulation of pituitary corticotropin releasing hormone receptors. Peptides, 22, 769-74 (2001)
12. Slominski, A., Wortsman, J., Linton, E., Pisarchik, A., Zbytek, B.: The skin as a model for the immunodulatory effects of corticotropin-releasing hormone. In: Mind over Matter - Regulation of Peripheral Inflammation by the CNS. Ed: M. Schäfer, Stein, C. Birkhäuser Verlag, Basel (2003)
13. Theoharides, T. C. & D. E. Cochrane: Critical role of mast cells in inflammatory diseases and the effect of acute stress. J Neuroimmunol, 146, 1-12 (2004)
14. Karalis, K., H. Sano, J. Redwine, S. Listwak, R. L. Wilder & G. P. Chrousos: Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science, 254, 421-3 (1991)
15. Pisarchik, A. & A. T. Slominski: Alternative splicing of CRH-R1 receptors in human and mouse skin: identification of new variants and their differential expression. Faseb J, 15, 2754-6 (2001)
16. Eckart, K., O. Jahn, J. Radulovic, M. Radulovic, T. Blank, O. Stiedl, O. Brauns, H. Tezval, T. Zeyda & J. Spiess: Pharmacology and biology of corticotropin-releasing factor (CRF) receptors. Receptors Channels, 8, 163-77 (2002)
17. Tsai-Morris, C. H., E. Buczko, Y. Geng, A. Gamboa-Pinto & M. L. Dufau: The genomic structure of the rat corticotropin releasing factor receptor. A member of the class II G protein-coupled receptors. J Biol Chem, 271, 14519-25 (1996)
18. Pisarchik, A. & A. Slominski: Corticotropin releasing factor receptor type 1: molecular cloning and investigation of alternative splicing in the hamster skin. J Invest Dermatol, 118, 1065-72 (2002)
19. Catalano, R. D., T. Kyriakou, J. Chen, A. Easton & E. W. Hillhouse: Regulation of corticotropin-releasing hormone type 2 receptors by multiple promoters and alternative splicing: identification of multiple splice variants. Mol Endocrinol, 17, 395-410 (2003)
20. Slominski, A., A. Pisarchik, D. J. Tobin, J. E. Mazurkiewicz & J. Wortsman: Differential expression of a cutaneous corticotropin-releasing hormone system. Endocrinology, 145, 941-50 (2004)
21. Pisarchik, A. & A. Slominski: Molecular and functional characterization of novel CRFR1 isoforms from the skin. European Journal of Biochemistry, 271, 2821-2830 (2004)
22. Slominski, A., Zbytek, B., Pisarchik, A., Slominski, R.M., Wortsman, J.: CRH functions as a growth factor/cytokine in the skin. J Cell Physiol DOI: 10.1002/jcp.20530 (2005)
23. Zbytek, B. & A. T. Slominski: Corticotropin-releasing hormone induces keratinocyte differentiation in the adult human epidermis. J Cell Physiol, 203, 118-26 (2005)
24. Slominski, A. T., V. Botchkarev, M. Choudhry, N. Fazal, K. Fechner, J. Furkert, E. Krause, B. Roloff, M. Sayeed, E. Wei, B. Zbytek, J. Zipper, J. Wortsman & R. Paus: Cutaneous expression of CRH and CRH-R. Is there a "skin stress response system?" Ann N Y Acad Sci, 885, 287-311 (1999)
25. Wiesner, B., B. Roloff, K. Fechner & A. Slominski: Intracellular calcium measurements of single human skin cells after stimulation with corticotropin-releasing factor and urocortin using confocal laser scanning microscopy. J Cell Sci, 116, 1261-8 (2003)
26. Wietfeld, D., N. Heinrich, J. Furkert, K. Fechner, M. Beyermann, M. Bienert & H. Berger: Regulation of the coupling to different G proteins of rat corticotropin-releasing factor receptor type 1 in human embryonic kidney 293 cells. J Biol Chem, 279, 38386-94 (2004)
27. Perrin, M. H., W. H. Fischer, K. S. Kunitake, A. G. Craig, S. C. Koerber, L. A. Cervini, J. E. Rivier, J. C. Groppe, J. Greenwald, S. Moller Nielsen & W. W. Vale: Expression, purification, and characterization of a soluble form of the first extracellular domain of the human type 1 corticotropin releasing factor receptor. J Biol Chem, 276, 31528-34 (2001)
28. Liaw, C. W., D. E. Grigoriadis, T. W. Lovenberg, E. B. De Souza & R. A. Maki: Localization of ligand-binding domains of human corticotropin-releasing factor receptor: a chimeric receptor approach. Mol Endocrinol, 11, 980-5 (1997)
29. Grammatopoulos, D. K., Y. Dai, H. S. Randeva, M. A. Levine, E. Karteris, A. J. Easton & E. W. Hillhouse: A novel spliced variant of the type 1 corticotropin-releasing hormone receptor with a deletion in the seventh transmembrane domain present in the human pregnant term myometrium and fetal membranes. Mol Endocrinol, 13, 2189-202 (1999)
30. Seck, T., R. Baron & W. C. Horne: The alternatively spliced deltae13 transcript of the rabbit calcitonin receptor dimerizes with the C1a isoform and inhibits its surface expression. J Biol Chem, 278, 23085-93 (2003)
31. Myers, D. A., J. V. Trinh & T. R. Myers: Structure and function of the ovine type 1 corticotropin releasing factor receptor (CRF1) and a carboxyl-terminal variant. Mol Cell Endocrinol, 144, 21-35 (1998)
32. Papadopoulou, N., J. Chen, H. S. Randeva, M. A. Levine, E. W. Hillhouse & D. K. Grammatopoulos: Protein kinase A-induced negative regulation of the corticotropin-releasing hormone R1alpha receptor-extracellularly regulated kinase signal transduction pathway: the critical role of Ser301 for signaling switch and selectivity. Mol Endocrinol, 18, 624-39 (2004)
33. Perrin, M. H., M. R. DiGruccio, S. C. Koerber, J. E. Rivier, K. S. Kunitake, D. L. Bain, W. H. Fischer & W. W. Vale: A soluble form of the first extracellular domain of mouse type 2beta corticotropin-releasing factor receptor reveals differential ligand specificity. J Biol Chem, 278, 15595-600 (2003)
34. Levine, S. J.: Mechanisms of soluble cytokine receptor generation. J Immunol, 173, 5343-8 (2004)
35. Yan, S. F., R. Ramasamy, Y. Naka & A. M. Schmidt: Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond. Circ Res, 93, 1159-69 (2003)
36. Slominski, A. T., B. Roloff, B. Zbytek, E. T. Wei, K. Fechner, J. Curry & J. Wortsman: Corticotropin releasing hormone and related peptides can act as bioregulatory factors in human keratinocytes. In Vitro Cell Dev Biol Anim, 36, 211-6 (2000)
37. Slominski, A., B. Zbytek, I. Semak, T. Sweatman & J. Wortsman: CRH stimulates POMC activity and corticosterone production in dermal fibroblasts. J Neuroimmunol, 162, 97-102 (2005)
38. Slominski, A., B. Zbytek, A. Szczesniewski, I. Semak, J. Kaminski, T. Sweatman & J. Wortsman: CRH stimulation of corticosteroids production in melanocytes is mediated by ACTH. Am J Physiol Endocrinol Metab, 288, E701-E706 (2005)
39. Fazal, N., A. Slominski, M. A. Choudhry, E. T. Wei & M. M. Sayeed: Effect of CRF and related peptides on calcium signaling in human and rodent melanoma cells. FEBS Letters, 435, 187-190 (1998)
40. Foreman, J., C., Johansen, T.: Textbook of Receptor Pharmacology. CRC Press, (2002)
41. Eckert, R. L., J. F. Crish, T. Efimova, S. R. Dashti, A. Deucher, F. Bone, G. Adhikary, G. Huang, R. Gopalakrishnan & S. Balasubramanian: Regulation of involucrin gene expression. J Invest Dermatol, 123, 13-22 (2004)
42. Zbytek, B., M. Pikula, R. M. Slominski, A. Mysliwski, E. Wei, J. Wortsman & A. T. Slominski: Corticotropin-releasing hormone triggers differentiation in HaCaT keratinocytes. Br J Dermatol, 152, 474-80 (2005)
43. Li, Q., Verma I., M.: NF-kB regulation in the immune system. Nature Reviews. Immunology, 2, 725-734 (2002)
44. Ullrich, S. E.: Does exposure to UV radiation induce a shift to a Th-2-like immune reaction? Photochem Photobiol, 64, 254-8 (1996)
45. Barker, J. N., R. S. Mitra, C. E. Griffiths, V. M. Dixit & B. J. Nickoloff: Keratinocytes as initiators of inflammation. Lancet, 337, 211-4 (1991)
46. Kupper, T. S. & R. C. Fuhlbrigge: Immune surveillance in the skin: mechanisms and clinical consequences. Nat Rev Immunol, 4, 211-22 (2004)
47. Nickoloff, B. J. & F. O. Nestle: Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities. J Clin Invest, 113, 1664-75 (2004)
48. Kondo, S. & K. Jimbow: Dose-dependent induction of IL-12 but not IL-10 from human keratinocytes after exposure to ultraviolet light A. J Cell Physiol, 177, 493-8 (1998)
49. Benou, C., Y. Wang, J. Imitola, L. VanVlerken, C. Chandras, K. P. Karalis & S. J. Khoury: Corticotropin-releasing hormone contributes to the peripheral inflammatory response in experimental autoimmune encephalomyelitis. J Immunol, 174, 5407-13 (2005)
50. Zbytek, B., A. Mysliwski, A. Slominski, J. Wortsman, E. T. Wei & J. Mysliwska: Corticotropin-releasing hormone affects cytokine production in human HaCaT keratinocytes. Life Sci, 70, 1013-21 (2002)
51. Quevedo, M. E., A. Slominski, W. Pinto, E. Wei & J. Wortsman: Pleiotropic effects of corticotropin releasing hormone on normal human skin keratinocytes. In Vitro Cell Dev Biol Anim, 37, 50-4 (2001)
52. Park, H. J., H. J. Kim, J. H. Lee, J. Y. Lee, B. K. Cho, J. S. Kang, H. Kang, Y. Yang & D. H. Cho: Corticotropin-releasing hormone (CRH) downregulates interleukin-18 expression in human HaCaT keratinocytes by activation of p38 mitogen-activated protein kinase (MAPK) pathway. J Invest Dermatol, 124, 751-5 (2005)
53. Zbytek, B., L. M. Pfeffer & A. T. Slominski: Corticotropin-releasing hormone inhibits nuclear factor-kappaB pathway in human HaCaT keratinocytes. J Invest Dermatol, 121, 1496-9 (2003)
54. Hagan, P., S. Poole & A. F. Bristow: Immunosuppressive activity of corticotrophin-releasing factor. Inhibition of interleukin-1 and interleukin-6 production by human mononuclear cells. Biochem J, 281 (Pt 1), 251-4 (1992)
55. Leu, S. J. & V. K. Singh: Stimulation of interleukin-6 production by corticotropin-releasing factor. Cell Immunol, 143, 220-7 (1992)
56. Zhao, J. & K. P. Karalis: Regulation of nuclear factor-kappaB by corticotropin-releasing hormone in mouse thymocytes. Mol Endocrinol, 16, 2561-70 (2002)
57. Lezoualc'h, F., S. Engert, B. Berning & C. Behl: Corticotropin- releasing hormone-mediated neuroprotection against oxidative stress is associated with the increased release of non-amyloidogenic amyloid beta precursor protein and with the suppression of nuclear factor-kappaB. Mol Endocrinol, 14, 147-59 (2000)
58. Paez Pereda, M., J. Sauer, C. Perez Castro, S. Finkielman, G. K. Stalla, F. Holsboer & E. Arzt: Corticotropin-releasing hormone differentially modulates the interleukin-1 system according to the level of monocyte activation by endotoxin. Endocrinology, 136, 5504-10 (1995)
59. Zbytek, B., L. M. Pfeffer & A. T. Slominski: Corticotropin-releasing hormone stimulates NF-kappaB in human epidermal keratinocytes. J Endocrinol, 181, R1-7 (2004)
60. Slominski, A. & J. Wortsman: Neuroendocrinology of the skin. Endocrine Rev, 21, 457-487 (2000)
61. Lehman, T. A., R. Modali, P. Boukamp, J. Stanek, W. P. Bennett, J. A. Welsh, R. A. Metcalf, M. R. Stampfer, N. Fusenig, E. M. Rogan & et al.: p53 mutations in human immortalized epithelial cell lines. Carcinogenesis, 14, 833-9 (1993)
62. Zbytek, B., Pfeffer, L., Slominski, A.: CRH inhibits NF-kappaB in melanocyte via POMC signaling.in preparation (2005)
63. Moustafa, M., M. Szabo, G. E. Ghanem, R. Morandini, E. H. Kemp, S. MacNeil & J. W. Haycock: Inhibition of tumor necrosis factor-alpha stimulated NFkappaB/p65 in human keratinocytes by alpha-melanocyte stimulating hormone and adrenocorticotropic hormone peptides. J Invest Dermatol, 119, 1244-53 (2002)
64. Haycock, J. W., M. Wagner, R. Morandini, G. Ghanem, I. G. Rennie & S. Mac Neil: Alpha-melanocyte-stimulating hormone inhibits NF-kappaB activation in human melanocytes and melanoma cells. J Invest Dermatol, 113, 560-6 (1999)
65. Roloff, B., K. Fechner, A. Slominski, J. Furkert, V. A. Botchkarev, S. Bulfone-Paus, J. Zipper, E. Krause & R. Paus: Hair cycle-dependent expression of Corticotropin-releasing factor (CRF) and CRF receptors in murine skin. Faseb J, 12, 287-97 (1998)
66. Slominski, A., G. Ermak, J. E. Mazurkiewicz, J. Baker & J. Wortsman: Characterization of corticotropin-releasing hormone (CRH) in human skin. J Clin Endocrinol Metab, 83, 1020-4 (1998)
67. Slominski, A., J. Baker, G. Ermak, A. Chakraborty & J. Pawelek: Ultraviolet B stimulates production of corticotropin releasing factor (CRF) by human melanocytes. FEBS Lett, 399, 175-6 (1996)
68. Slominski, A., B. Roloff, J. Curry, M. Dahiya, A. Szczesniewski & J. Wortsman: The skin produces urocortin. J Clin Endocrinol Metab, 85, 815-23 (2000)
69. Slominski, A., A. Szczesniewski & J. Wortsman: Liquid chromatography-mass spectrometry detection of corticotropin-releasing hormone and proopiomelanocortin-derived peptides in human skin. J Clin Endocrinol Metab, 85, 3582-8 (2000)
70. Zouboulis, C. C., H. Seltmann, N. Hiroi, W. Chen, M. Young, M. Oeff, W. A. Scherbaum, C. E. Orfanos, S. M. McCann & S. R. Bornstein: Corticotropin-releasing hormone: an autocrine hormone that promotes lipogenesis in human sebocytes. Proc Natl Acad Sci U S A, 99, 7148-53 (2002)
71. Cao, J., N. Papadopoulou, D. Kempuraj, W. S. Boucher, K. Sugimoto, C. L. Cetrulo & T. C. Theoharides: Human Mast Cells Express Corticotropin- Releasing Hormone (CRH) Receptors and CRH Leads to Selective Secretion of Vascular Endothelial Growth Factor. J Immunol, 174, 7665-75 (2005)
72. Kono, M., H. Nagata, S. Umemura, S. Kawana & R. Y. Osamura: In situ expression of corticotropin-releasing hormone (CRH) and proopiomelanocortin (POMC) genes in human skin. Faseb J, 15, 2297-9 (2001)
73. Ito, N., T. Ito, A. Betterman & R. Paus: The human hair bulb is a source and target of CRH. J Invest Dermatol, 122, 235-7 (2004)
74. Ito, N., T. Ito, A. Kromminga, A. Bettermann, M. Takigawa, F. Kees, R. H. Straub & R. Paus: Human hair follicles display a functional equivalent of the hypothalamic-pituitary-adrenal (HPA) axis and synthesize cortisol. Faseb J, 10.1096/fj.04-1968fje., Published online June 9, 2005. (2005)
75. Slominski, A., G. Ermak, J. Hwang, J. Mazurkiewicz, D. Corliss & A. Eastman: The expression of proopiomelanocortin (POMC) and of corticotropin releasing hormone receptor (CRH-R) genes in mouse skin. Biochim Biophys Acta, 1289, 247-51 (1996)
76. Chen, A., A. Blount, J. Vaughan, B. Brar & W. Vale: Urocortin II gene is highly expressed in mouse skin and skeletal muscle tissues: localization, basal expression in corticotropin-releasing factor receptor (CRFR) 1- and CRFR2-null mice, and regulation by glucocorticoids. Endocrinology, 145, 2445-57 (2004)
77. Clifton, V. L., R. Crompton, M. A. Read, P. G. Gibson, R. Smith & I. M. Wright: Microvascular effects of corticotropin-releasing hormone in human skin vary in relation to estrogen concentration during the menstrual cycle. J Endocrinol, 186, 69-76 (2005)
78. Clifton, V. L., R. Crompton, R. Smith & I. M. Wright: Microvascular effects of CRH in human skin vary in relation to gender. J Clin Endocrinol Metab, 87, 267-70 (2002)
79. Crompton, R., V. L. Clifton, A. T. Bisits, M. A. Read, R. Smith & I. M. Wright: Corticotropin-releasing hormone causes vasodilation in human skin via mast cell-dependent pathways. J Clin Endocrinol Metab, 88, 5427-32 (2003)
80. Arbiser, J. L., K. Karalis, A. Viswanathan, C. Koike, B. Anand-Apte, E. Flynn, B. Zetter & J. A. Majzoub: Corticotropin-releasing hormone stimulates angiogenesis and epithelial tumor growth in the skin. J Invest Dermatol, 113, 838-42 (1999)
81. Tjuvajev, J., Y. Kolesnikov, R. Joshi, J. Sherinski, L. Koutcher, Y. Zhou, C. Matei, J. Koutcher, M. J. Kreek & R. Blasberg: Anti-neoplastic properties of human corticotropin releasing factor: involvement of the nitric oxide pathway. In Vivo, 12, 1-10 (1998)
82. Wei, E. T. & H. A. Thomas: Correlation of neuroendocrine and anti-edema activities of alanine-corticotropin-releasing factor analogs. Eur J Pharmacol, 263, 319-21 (1994)
83. Gjerde, E. A., K. Woie, E. T. Wei & R. K. Reed: Corticotropin- releasing hormone inhibits lowering of interstitial pressure in rat trachea after neurogenic inflammation. Eur J Pharmacol, 352, 99-102 (1998)
84. Torpy, D. J., E. L. Webster, E. K. Zachman, G. Aguilera & G. P. Chrousos: Urocortin and inflammation: confounding effects of hypotension on measures of inflammation. Neuroimmunomodulation, 6, 182-6 (1999)
85. Slominski, A., J. Wortsman, J. E. Mazurkiewicz, L. Matsuoka, J. Dietrich, K. Lawrence, A. Gorbani & R. Paus: Detection of proopiomelanocortin-derived antigens in normal and pathologic human skin. J Lab Clin Med, 122, 658-66 (1993)
86. Slominski, A., R. Paus & J. Wortsman: On the potential role of proopiomelanocortin in skin physiology and pathology. Mol Cell Endocrinol, 93, C1-C6 (1993)
87. Katsarou-Katsari, A., L. K. Singh & T. C. Theoharides: Alopecia areata and affected skin CRH receptor upregulation induced by acute emotional stress. Dermatology, 203, 157-61 (2001)
88. Slominski, A., D. J. Tobin, S. Shibahara & J. Wortsman: Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev, 84, 1155-228 (2004)
89. Slominski, A., D. Heasley, J. E. Mazurkiewicz, G. Ermak, J. Baker & J. A. Carlson: Expression of proopiomelanocortin (POMC)-derived melanocyte-stimulating hormone (MSH) and adrenocorticotropic hormone (ACTH) peptides in skin of basal cell carcinoma patients. Hum Pathol, 30, 208-15 (1999)
90. Kauser, S., A. J. Thody, K. U. Schallreuter, C. L. Gummer & D. J. Tobin: beta-Endorphin as a regulator of human hair follicle melanocyte biology. J Invest Dermatol, 123, 184-95 (2004)
91. Kauser, S., A. J. Thody, K. U. Schallreuter, C. L. Gummer & D. J. Tobin: A fully functional proopiomelanocortin/melanocortin-1 receptor system regulates the differentiation of human scalp hair follicle melanocytes. Endocrinology, 146, 532-43 (2005)
92. Slominski, A., J. Wortsman, P. M. Plonka, K. U. Schallreuter, R. Paus & D. J. Tobin: Hair follicle pigmentation. J Invest Dermatol, 124, 13-21 (2005)
93. Paus, R., V. A. Botchkarev, N. V. Botchkareva, L. Mecklenburg, T. Luger & A. Slominski: The skin POMC system (SPS). Leads and lessons from the hair follicle. Ann N Y Acad Sci, 885, 350-63 (1999)
94. Stander, S., M. Bohm, T. Brzoska, K. P. Zimmer, T. Luger & D. Metze: Expression of melanocortin-1 receptor in normal, malformed and neoplastic skin glands and hair follicles. Exp Dermatol, 11, 42-51 (2002)
95. Bohm, M., M. Eickelmann, Z. Li, S. W. Schneider, V. Oji, S. Diederichs, G. S. Barsh, A. Vogt, K. Stieler, U. Blume-Peytavi & T. A. Luger: Detection of functionally active melanocortin receptors and evidence for an immunoregulatory activity of {alpha}-melanocyte-stimulating hormone in human dermal papilla cells. Endocrinology (2005)
96. Zouboulis, C. C. & M. Bohm: Neuroendocrine regulation of sebocytes - a pathogenetic link between stress and acne. Exp Dermatol, 13 Suppl 4, 31-5 (2004)
97. Zouboulis, C. C. & K. Degitz: Androgen action on human skin - from basic research to clinical significance. Exp Dermatol, 13 Suppl 4, 5-10 (2004)
98. Arck, P., C. Slominski, A. Theoharides, T.C. Peters, E.M.J. Paus, R: Neurobiology of Stress: Skin takes center stage. J Invest Dermatolin press (2005)
99. Kauser, S., A. Slominski, E. Wei, T, & D. Tobin, J: Modulation of the human hair follicle pigmentary unit by CRH and urocotrin peptides. FASEB J, Submitted
100. Tobin, D. J.: Biology of hair pigmentation. In: Hair, Nail and Skin. Eds: B. Forslind & M. Lindberg. Marcel Dekker, New York (2004)
101. Tobin, D. J. & J. C. Bystryn: Different populations of melanocytes are present in hair follicles and epidermis. Pigment Cell Res, 9, 304-10 (1996)
102. Kauser, S., A. Slominski, E. Wei & D. J. Tobin: Corticotropin- releasing hormone and related peptides stimulate follicular melanocyte behaviour in vitro and also modulate human hair fibre elongation in organ culture. Journal of the German Society of Dermatology, 6, 494 (2004)
103. Tobin, D. J. & R. Paus: Graying: gerontobiology of the hair follicle pigmentary unit. Exp Gerontol, 36, 29-54 (2001)
104. Wei, E. T., H. A. Thomas, H. C. Christian, J. C. Buckingham & T. Kishimoto: D-amino acid-substituted analogs of corticotropin-releasing hormone (CRH) and urocortin with selective agonist activity at CRH1 and CRH2beta receptors. Peptides, 19, 1183-90 (1998)
105. Slominski, A. & M. C. Mihm: Potential mechanism of skin response to stress. Int J Dermatol, 35, 849-51 (1996)
106. Slominski, A., J. Zjawiony, J. Wortsman, I. Semak, J. Stewart, A. Pisarchik, T. Sweatman, J. Marcos, C. Dunbar & C. T. R: A novel pathway for sequential transformation of 7-dehydrocholesterol and expression of the P450scc system in mammalian skin. Eur J Biochem, 271, 4178-88 (2004)
107. Slominski, A., C. E. Gomez-Sanchez, M. F. Foecking & J. Wortsman: Metabolism of progesterone to DOC, corticosterone and 18OHDOC in cultured human melanoma cells. FEBS Lett, 455, 364-6 (1999)
108. Slominski, A., G. Ermak & M. Mihm: ACTH receptor, CYP11A1, CYP17 and CYP21A2 genes are expressed in skin. J Clin Endocrinol Metab, 81, 2746-9 (1996)
109. Slominski, A. & M. Mihm: Potential mechanism of skin response to stress. Int J Dermatol, 35, 849-851 (1996)
110. Carlson, K. W., S. S. Nawy, E. T. Wei, W. Sadee, V. A. Filov, V. V. Rezsova, A. Slominski & J. M. Quillan: Inhibition of mouse melanoma cell proliferation by corticotropin-releasing hormone and its analogs. Anticancer Res, 21, 1173-9 (2001)
111. Krogh, A., B. Larsson, G. von Heijne & E. L. Sonnhammer: Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol, 305, 567-80 (2001)
112. Tusnady, G. E. & I. Simon: The HMMTOP transmembrane topology prediction server. Bioinformatics, 17, 849-50 (2001)
113. Horn, F., E. Bettler, L. Oliveira, F. Campagne, F. E. Cohen & G. Vriend: GPCRDB information system for G protein-coupled receptors. Nucleic Acids Res, 31, 294-7 (2003)
114. Baldwin, J. M., G. F. Schertler & V. M. Unger: An alpha-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors. J Mol Biol, 272, 144-64 (1997)